ClinicalTrials.gov
ClinicalTrials.gov Menu

Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC) (Dengshan)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01124253
Recruitment Status : Completed
First Posted : May 17, 2010
Last Update Posted : May 17, 2010
Sponsor:
Collaborators:
Shanghai Municipal Science and Technology Commission
Shanghai Chest Hospital
Simcere Pharmaceutical Co., Ltd
Information provided by:
Shanghai Jiao Tong University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2009
  Actual Study Completion Date : October 2009